In glioblastoma, NAMPT inhibitors can upregulate PD-L1 in tumor cells, which makes combination therapy with NAMPT inhibitor and blockade of the PD-L1/PD-1 axis more efficient (46). The gene discussed is CD274; the disease is glioblastoma.